Evidence map›Paper›PMID 36128586›Full record

ArticleNeuro-oncology advances

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases.

Daniele Procissi, Stephen A Jannetti, Markella Zannikou, Zhengyuan Zhou, Darryl McDougald, Deepak Kanojia, Hui Zhang, Kirsten Burdett, Ganesan Vaidyanathan, Michael R Zalutsky and 1 more

Open access · goldAbstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Daniele ProcissiDepartment of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
Stephen A Jannetti
Markella ZannikouDepartment of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
Zhengyuan ZhouDepartment of Radiology, Duke University Medical Center, Durham, North Carolina, USA.
Darryl McDougaldDepartment of Radiology, Duke University Medical Center, Durham, North Carolina, USA.
Deepak KanojiaDepartment of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
Hui ZhangDepartment of Preventive Medicine, Northwestern University, Chicago, Illinois, USA.
Kirsten BurdettDepartment of Preventive Medicine, Northwestern University, Chicago, Illinois, USA.
Ganesan VaidyanathanDepartment of Radiology, Duke University Medical Center, Durham, North Carolina, USA.
Michael R ZalutskyDepartment of Radiology, Duke University Medical Center, Durham, North Carolina, USA.
Irina V BalyasnikovaDepartment of Neurological Surgery, Northwestern University, Chicago, Illinois, USA.
Northwestern University · USDuke Medical Center · US

Funding

RADIOTHERAPY USING MONOCLONAL ANTIBODIES AND ASTATINER01CA042324 · NCI · DUKE UNIVERSITY · PI ZALUTSKY, MICHAEL ROD · 1985 to 2020
$4.6M
ASTATINE AND IODINE RADIOLABELED MONOCLONAL ANTIBODIESR37CA042324 · NCI · DUKE UNIVERSITY · PI ZALUTSKY, MICHAEL ROD · 1999 to 2008
$3.8M
Labeling nanobodies with 18F residualizing labels for HER2 specific PET imagingR01CA188177 · NCI · DUKE UNIVERSITY · PI VAIDYANATHAN, GANESAN · 2015 to 2019
$1.8M
NCI NIH HHS R01 CA042324NCI NIH HHS R01 CA188177NCI NIH HHS R37 CA042324
6 · The paper itself

Abstract

Background: Single-domain antibody fragments (aka V Methods: Mice with intracranial HER2-positive BT474BrM3 tumors received 10-Gy fractionated cranial irradiation and were evaluated by noninvasive imaging. Anti-HER2 V Results: Increased Conclusion: Low-level brain irradiation induces dynamic changes in tumor vasculature that increase the intracranial tumor delivery of an anti-HER2 V

Indexed as

breast cancer brain metastasesHER2PETsingle-domain antibody fragmentVHH

Identifiers

PMID36128586
PMCPMC9476215
OpenAlexW4292787967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.